Yes, it is not understood by most new investors in the lithium brine businesses that the chemical process is tricky in a lab but nearly impossible on an industrial scale (for most operators)
Jerko’s decision to align AGY with Pablo was his master stroke.
This does imply that wither we go, Pablo goeth or we don’t go at all.
Let’s raise a toast to a long “marriage.”
And then your train of thought can, and probably will, become a reality.
- Forums
- ASX - By Stock
- AGY
- Li-related News/Articles/Reports
Li-related News/Articles/Reports, page-4180
Featured News
Add AGY (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $50.95M |
Open | High | Low | Value | Volume |
3.7¢ | 3.7¢ | 3.5¢ | $116.1K | 3.177M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
29 | 3422978 | 3.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.6¢ | 117789 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
29 | 3422978 | 0.035 |
17 | 2085124 | 0.034 |
12 | 1403935 | 0.033 |
4 | 715000 | 0.032 |
3 | 504333 | 0.031 |
Price($) | Vol. | No. |
---|---|---|
0.036 | 117789 | 2 |
0.037 | 1603662 | 11 |
0.038 | 1521677 | 7 |
0.039 | 1495481 | 8 |
0.040 | 720475 | 4 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
AGY (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online